Transcripts - Operator Good day, and welcome to the GENFIT Positive Top Line Data from Phase III ELATIVE trial of elafibranor in patients with Primary Biliary Cholangitis … Continue Reading
Read nowInsights - Radiopharmaceutical companies are primed for increased investor interest as the sector is seeing meaningful progress that is currently being overlooked in favor of ADCs. Tailwinds … Continue Reading
Read nowTranscripts - Operator Good morning, and welcome to the BioXcel Therapeutics TRANQUILITY II Top Line Results Conference Call. [Operator Instructions] Just to remind everyone, certain matters discussed … Continue Reading
Read nowTranscripts - Operator Thank you for standing by. Welcome to Nkarta Conference Call to review the clinical update for NKX101. At this time, all participants are in … Continue Reading
Read nowTranscripts - Operator Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics conference call to present the positive Phase II results of … Continue Reading
Read nowInsights - Obesity data from big pharma competitors was presented at the American Diabetes Association conference this past weekend. The trend is moving towards developing oral GLP-1 … Continue Reading
Read nowTranscripts - Operator Good afternoon, and welcome to the Sarepta Therapeutics ELEVIDYS FDA accelerated approval call. [Operator Instructions] As a reminder, today’s program is being recorded. At … Continue Reading
Read now
